m-lab GmbH

We are a German biotech company dedicated to the development of Lateral Flow Assays for point-of-care diagnosis, antibody-based treatments and reader software development. Our goal is to prevent blindness caused by glaucoma. Therefor, at m-lab we are committed to commercialize a glaucoma diagnostic platform that will provide the general population easy, affordable and widespread access to disease detection and early treatment initiation. Initially focusing on glaucoma, we are presently expanding our research interests to include other targets and other pathologies. To learn more, visit us at http://m-lab.com/